550 related articles for article (PubMed ID: 17141215)
1. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
[TBL] [Abstract][Full Text] [Related]
2. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
Eur J Pharmacol; 2007 Jun; 564(1-3):196-203. PubMed ID: 17328887
[TBL] [Abstract][Full Text] [Related]
3. Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis.
Arai I; Takano N; Hashimoto Y; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakaike S
Eur J Pharmacol; 2004 Nov; 505(1-3):229-35. PubMed ID: 15556157
[TBL] [Abstract][Full Text] [Related]
4. Role of scratch-induced cutaneous prostaglandin D production on atopic-like scratching behaviour in mice.
Takaoka A; Arai I; Sugimoto M; Futaki N; Sakurai T; Honma Y; Nakaike S
Exp Dermatol; 2007 Apr; 16(4):331-9. PubMed ID: 17359340
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin D2 and prostaglandin E2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice.
Honma Y; Arai I; Hashimoto Y; Futaki N; Sugimoto M; Tanaka M; Nakaike S
Eur J Pharmacol; 2005 Jul; 518(1):56-62. PubMed ID: 16000196
[TBL] [Abstract][Full Text] [Related]
6. Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC/Nga mice with atopic dermatitis.
Negi O; Tominaga M; Tengara S; Kamo A; Taneda K; Suga Y; Ogawa H; Takamori K
J Dermatol Sci; 2012 Apr; 66(1):37-43. PubMed ID: 22381253
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone.
Inagaki N; Shiraishi N; Igeta K; Itoh T; Chikumoto T; Nagao M; Kim JF; Nagai H
Eur J Pharmacol; 2006 Sep; 546(1-3):189-96. PubMed ID: 16914137
[TBL] [Abstract][Full Text] [Related]
8. Increased scratching counts depend on a decrease in ability of cutaneous prostaglandin D2 biosynthesis in NC/Nga mice with atopic dermatitis.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Honma Y; Nakaike S
Exp Dermatol; 2005 Dec; 14(12):898-905. PubMed ID: 16274457
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antipruritic effects of several agents on scratching behavior by NC/Nga mice.
Takano N; Arai I; Hashimoto Y; Kurachi M
Eur J Pharmacol; 2004 Jul; 495(2-3):159-65. PubMed ID: 15249165
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of combination using glucosamine plus tacrolimus (FK-506) on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
Kim CH; Cheong KA; Park CD; Lee AY
Scand J Immunol; 2012 May; 75(5):471-8. PubMed ID: 22023698
[TBL] [Abstract][Full Text] [Related]
11. Time course changes of scratching counts, dermatitis symptoms, and levels of cutaneous prostaglandins in NC/Nga mice.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
Exp Dermatol; 2006 Nov; 15(11):875-82. PubMed ID: 17002684
[TBL] [Abstract][Full Text] [Related]
12. Effects of indomethacin and dexamethasone on mechanical scratching-induced cutaneous barrier disruption in mice.
Honma Y; Arai I; Sakurai T; Futaki N; Hashimoto Y; Sugimoto M; Nakanishi Y; Nakaike S
Exp Dermatol; 2006 Jul; 15(7):501-8. PubMed ID: 16761958
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice.
Tanizaki H; Kambe N; Nakamura Y; Tanaka A; Matsuda H; Miyachi Y
Int Arch Allergy Immunol; 2008; 145(4):277-82. PubMed ID: 18004068
[TBL] [Abstract][Full Text] [Related]
14. Depletion of substance P, a mechanism for inhibition of mouse scratching behavior by tacrolimus.
Inagaki N; Shiraishi N; Igeta K; Nagao M; Kim JF; Chikumoto T; Itoh T; Katoh H; Tanaka H; Nagai H
Eur J Pharmacol; 2010 Jan; 626(2-3):283-9. PubMed ID: 19818345
[TBL] [Abstract][Full Text] [Related]
15. Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis.
Grimstad O; Sawanobori Y; Vestergaard C; Bilsborough J; Olsen UB; Grønhøj-Larsen C; Matsushima K
Exp Dermatol; 2009 Jan; 18(1):35-43. PubMed ID: 19054054
[TBL] [Abstract][Full Text] [Related]
16. Putative mechanism of the itch-scratch circle: repeated scratching decreases the cutaneous level of prostaglandin D2, a mediator that inhibits itching.
Sugimoto M; Arai I; Futaki N; Honma Y; Sakurai T; Hashimoto Y; Nakaike S
Prostaglandins Leukot Essent Fatty Acids; 2007 Feb; 76(2):93-101. PubMed ID: 17250998
[TBL] [Abstract][Full Text] [Related]
17. Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model.
Takano N; Sakurai T; Ohashi Y; Kurachi M
Br J Dermatol; 2007 Feb; 156(2):241-6. PubMed ID: 17223862
[TBL] [Abstract][Full Text] [Related]
18. A method to induce stable atopic dermatitis-like symptoms in NC/Nga mice housed with skin-lesioned mice.
Takano N; Arai I; Kurachi M
Br J Dermatol; 2006 Mar; 154(3):426-30. PubMed ID: 16445770
[TBL] [Abstract][Full Text] [Related]
19. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis.
Takaoka A; Arai I; Sugimoto M; Honma Y; Futaki N; Nakamura A; Nakaike S
Exp Dermatol; 2006 Mar; 15(3):161-7. PubMed ID: 16480423
[TBL] [Abstract][Full Text] [Related]
20. COX-1 inhibition enhances scratching behaviour in NC/Nga mice with atopic dermatitis.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Honma Y; Nakaike S
Exp Dermatol; 2006 Aug; 15(8):582-8. PubMed ID: 16842596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
